Abstract
Objective: Bi-allelic mutations in PRKN lead to early onset Parkinson disease (PD), yet there are contradicting results regarding the role of heterozygous PRKN mutations in PD. Herein, we aimed to examine the effect of heterozygous PRKN single nucleotide variants (SNV) and copy number variation (CNV) in PD.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
